Steve Schonfeld’s Biofrontera BFRI Stock Holding History

Steve Schonfeld’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,425	Closed	-$46K	–	1789
2023 Q2	$46K	Sell	4,425 -20	-0.4%	-$212	﹤0.01%	1820
2023 Q1	$54.2K	Sell	4,445 -140	-3%	-$2.18K	﹤0.01%	1762
2022 Q4	$84.1K	Buy	4,585 +20	+0.4%	+$408	﹤0.01%	2218
2022 Q3	$96K	Sell	4,565 -30	-0.7%	-$820	﹤0.01%	2567
2022 Q2	$171K	Buy	4,595 +130	+3%	+$7.89K	﹤0.01%	1958
2022 Q1	$298K	Buy	+4,465	New	+$324K	﹤0.01%	1696

Other funds holding BFRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CSPIA

Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Steve Schonfeld's BFRI Position: Q3 2023 in Review

Steve Schonfeld sold out of Biofrontera (BFRI) in Q3 2023, closing a stake of 4,425 shares — an estimated $46K sold.

Steve Schonfeld first reported a position in BFRI in Q1 2022 and held it in 6 quarters. The position peaked at $298K in Q1 2022. 8 funds tracked by Wall St. Rank hold BFRI as of Q3 2023.

Steve Schonfeld reported no remaining Biofrontera position as of Q3 2023 after selling out during the quarter.
Steve Schonfeld sold 4,425 Biofrontera shares in Q3 2023, an estimated $46K.
Steve Schonfeld first reported a position in Biofrontera in Q1 2022 and held it in 6 quarters.
Steve Schonfeld's Biofrontera position peaked at $298K in Q1 2022.
8 funds tracked by Wall St. Rank held Biofrontera as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.